Login
Toggle navigation
Videos
Categories
Trending
Presentation: Packaging Progress - Ditching Plastic to Reduce Emissions | Thomas Körmendi - CEO of Elopak Group.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Thomas Körmendi is the CEO and President of the Elopak Group.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Mellody Hobson's Trailblazing Leadership at Ariel Investments and Innovative Strategies to Narrow the Racial Wealth Gap
00:10:00
French Snap Elections: Market Implications with Thomas Stokes and Guillaume Paillat
00:10:00
Final Tips for Effective Online Training Sessions
00:10:00
Gold Source: Developing Guyana's Eagle Mountain Project with 1.7M Ounces in Resources
00:10:00
From Tinkering with Appliances to Transforming Clinical Trials|Ryan Jones,CEO,Florence Healthcare
00:10:00
First Gen Corp. reported a net income of P15.4 billion in 2023, reflecting strong financial performance.
00:10:00
Inflation Concerns: Understanding Causes and Preparing for the Future | Jennifer Luzzatto, President, Summit Financial Partners, Inc.
00:10:00
Mike Crawley Discusses Company's Growth, Renewable Energy Focus, and Transition Plans | Mike Crawley, CEO, Northland Power Inc .
00:10:00
Embracing Diversity in Brussels: Harold Boël at Digityser's Grand Opening | Harold Boël, CEO, Sofina.
00:10:00
Alsea International CEO Fabián Gosselin Praises Forbes México for Valuable Business Insights | Fabián Gosselin, CEO , Alsea SAB de CV.
00:10:00
Profitability Surges Despite Slower Growth, Focus on Market Optimization and Adaptation | Niilo Fredrikson , CEO of Efecte Oyj
00:10:00
Revival Gold Expands High-Grade Resource at Beartrack-Arnett